Access and Rational use of Plasma Protein Therapies (PPTs)

Journal Title: Iranian Journal of Blood and Cancer - Year 2011, Vol 3, Issue 3

Abstract

This article has no abstract.

Authors and Affiliations

Albert Farrugia

Keywords

Related Articles

Autoimmune Lymphoproliferative Syndrome Misdiagnosed as Hemophagocytic Lymphohistiocytosis A Case Report

Autoimmune lymphoproliferative Syndrome (ALPS) is a rare inherited disorder of apoptosis. It usually presents with chronic lymphadenopathy, splenomegaly, and symptomatic cytopenia in a child. Herein, we report a 14-year-...

In-Vitro Red Blood Cells Integrity and Morphology Changes after Passing Through Volumetric Peristaltic Infusion Pump

Background: It is not clear whether the use of volumetric peristaltic infusion pumps, affect the quality of the erythrocytes during packed cell transfusion or not. In the present study in vitro quality of red blood cells...

The Comparison of Efficacy of Original Brand Deferoxamine with Generic Iranian Made Deferoxamine in Urinary Iron Excretion in Patients with Thalassemia Major

Background: Deferoxamine mesylate is still the conventional and well-known iron chelator for patients with thalassemia major. However, due to some marketing issues the well-known original brand, Desferal®, produced by No...

Investigation of Leptin, Leukemia Inhibitory Factor (LIF), and IL-6 Serum Levels in Myeloid Leukemia

Background: Leptin has been implicated in the differentiation and proliferation of hematopoietic cells. Leukemia inhibitory factor (LIF) may play an important role, along with Interleukin-6 (IL-6) and granulocyte colony...

Editorial

This article has no abstract.

Download PDF file
  • EP ID EP370822
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Albert Farrugia (2011). Access and Rational use of Plasma Protein Therapies (PPTs). Iranian Journal of Blood and Cancer, 3(3), 151-158. https://europub.co.uk/articles/-A-370822